skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

The role of rifaximin in the treatment and chemoprophylaxis of travelers' diarrhea

Review

(1970) Views  (897) Full article downloads

Authors: Hoonmo L Koo, Herbert L DuPont, David B Huang

Published Date October 2009 Volume 2009:5 Pages 841 - 848
DOI: http://dx.doi.org/10.2147/TCRM.S4442

Hoonmo L Koo1,2, Herbert L DuPont1,2, David B Huang3

1Baylor College of Medicine, Houston, TX, USA; 2University of Texas at Houston School of Public Health, Houston, TX, USA; 3Veterans Affairs Medical Center, East Orange, NJ, USA

Abstract: Travelers’ diarrhea is a common illness among international travelers from developed to developing countries. Travelers’ diarrhea is caused by ingestion of contaminated food and water. Bacteria are the primary cause of travelers’ diarrhea. In most surveys, the most common diarrheal pathogen identified is enterotoxigenic Escherichia coli. There are several antimicrobial agents available for the treatment of travelers’ diarrhea including rifaximin which is approved in the United States for the treatment of travelers’ diarrhea due to noninvasive E. coli strains. In this review, we will review the most recent advances of rifaximin for the treatment and prevention of travelers’ diarrhea, with regard to its pharmacokinetics, in vitro susceptibility profile, and efficacy and safety data from clinical trials.

Keywords: travelers’ diarrhea, rifaximin, treatment, prevention








Readers of this article also read:

Anticholinergic syndrome following an unintentional overdose of scopolamine
Safety and efficacy of telbivudine for the treatment of chronic hepatitis B
Antimicrobial prophylaxis in colorectal surgery: focus on ertapenem
Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis
New therapies in the management of Niemann-Pick type C disease: clinical utility of miglustat
Celecoxib in arthritis: relative risk management profile and implications for patients
Pharmacological and combined interventions for the acute depressive episode: focus on efficacy and tolerability
Exercise-induced bronchoconstriction: The effects of montelukast, a leukotriene receptor antagonist
Phenotype characterization of embryoid body structures generated by a crystal comet effect tail in an intercellular cancer collision scenario
Requested meals versus scheduled meals